Comorbidity leads to poorer survival in patients with renal cell carcinoma in Danish cohort study
In a cohort study based on data from a national register of Danish patients with renal cell carcinoma with follow-up for up to 13 years, Post.doc. Trine Allerslev from the Danish Cancer Society looked at comorbidity as a prognostic factor for survival in elderly (≥70 years) and younger (<70 years) patients. Data was presented at ASCO GU 2021.
Get access to the article
If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.